Reference
Alberts, A.W., et al., Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent.
Proc. Natl. Acad. Sci. USA 77, 3957-3961, (1980)
abstract
Ghosh, P.M., et al., Lovastatin induces apoptosis by inhibiting mitotic and post-mitotic events in cultured mesangial cells.
Biochim. Biophys. Acta 1359, 13-24, (1997)
abstract
van de Donk, N.W., et al., The cholesterol lowering drug lovastatin induces cell death in myeloma plasma cells.
Leukemia 16, 1362-1371, (2002)
abstract
Bardeleben, R.V., et al., The HMG-CoA reductase inhibitor lovastatin protects cells from the antineoplastic drugs doxorubicin and etoposide.
Int. J. Mol. Med. 10, 473-479, (2002)
abstract
Muller, C., et al., Lovastatin inhibits proliferation of pancreatic cancer cell lines with mutant as well as with wild-type K-ras oncogene but has different effects on protein phosphorylation and induction of apoptosis.
Int. J. Oncol. 12, 717-723, (1998)
abstract
Maksumova, L., et al., Increased sensitivity of multidrug-resistant myeloid leukemia cell lines to lovastatin.
Leukemia 14, 1444-1450, (2000)
abstract
Zhong, W.B., et al., Lovastatin induces apoptosis of anaplastic thyroid cancer cells via inhibition of protein geranylgeranylation and de novo protein synthesis.
Endocrinology 144, 3852-3859, (2003)
abstract
Agarwal, B., et al., Mechanism of lovastatin-induced apoptosis in intestinal epithelial cells.
Carcinogenesis 23, 521-528, (2002)
abstract